evaluation of biochemical parameters of platelet concentrates stored in plasma or in a platelet additive solution (composol)

Authors

ha izadpanahi blood transfusion research center, high institute for research and education in transfusion medicine, tehran, iran

fateme yari blood transfusion research center, high institute for research and education in transfusion medicine, tehran, iranسازمان اصلی تایید شده: سازمان انتقال خون ایران (blood transfusion research center)

mr khorramizadeh department of pathobiology, school of public health, medical sciences/ university of tehran, iranسازمان اصلی تایید شده: سازمان انتقال خون ایران (blood transfusion research center)

m maghsudlu blood transfusion research center, high institute for research and education in transfusion medicine, tehran, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences)

abstract

abstract objective removing plasma from the platelet concentrate (pc) medium could be an effective way to increase the safety of this product. the goal of this study was to compare pc stored in plasma or in an additive solution (composol) with in vitro testing. materials and methods fifty-four single donor pcs were prepared from iranian blood transfusion organization (ibto). each pc unit was divided into two portions. then in one of the portions, plasma was replaced with composol. sampling was carried out at the days 2, 4 and 7 from the preparation time. the levels of ph, glucose, lactate and lactate dehydrogenase (ldh) were analyzed by colorimetric methods. results the levels of ph and glucose were decreased during storage whereas the levels of ldh and lactate were increased with time over. at the day 7 of storage, the mean values for glucose were 404.44 and 25.19 mg/dl in plasma and composol, respectively. these values were 3306.1 and 683.33 u/l for ldh and 142.07 and 90.90 mg/dl for lactate. the differences between ldh, lactate, and glucose levels were significant between the two storage media of plasma and composol (p-value< 0.001). conclusion this study could imply the potential capacity of an additive solution as a candidate for plasma replacement in pc in vitro.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Evaluation of Biochemical Parameters of Platelet Concentrates Stored in Plasma or in A Platelet Additive Solution (Composol)

Abstract Objective Removing plasma from the platelet concentrate (PC) medium could be an effective way to increase the safety of this product. The goal of this study was to compare PC stored in plasma or in an additive solution (Composol) with in vitro testing. Materials and Methods Fifty-four single donor PCs were prepared from Iranian Blood Transfusion Organization (IBTO). Each PC unit wa...

full text

Evaluation of biochemical parameters in platelet concentrates stored in glucose solution.

BACKGROUND Therapeutic storage of platelet concentrate is a challenging problem for Transfusion Medicine, so that many studies have been carried out with the aim of improving the duration of storage of platelet concentrates. Little attention, however, has been given to the most appropriate biochemical methods for evaluating the quality of the stored platelet concentrates. MATERIAL AND METHODS...

full text

Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction.

Pathogen reduction (PR) of platelet products increases costs and available clinical studies are equivocal with respect to clinical and haemostatic effectiveness. We conducted a multicentre, open-label, randomized, non-inferiority trial comparing the clinical effectiveness of buffy-coat derived leukoreduced platelet concentrates (PC) stored for up to 7 d in plasma with platelets stored in platel...

full text

Evaluation of microRNAs; mir223, mir222 and mir92a levels in the Platelet-derived microparticles in the Platelet concentrates produced by Platelet Rich Plasma method during storage

Abstract Background and Objectives Platelets release microparticles containing cellular components, including microRNAs, during storage. Assessment of these microRNAs is one of the markers for evaluation of platelet storage lesions. The aim of the present study was to evaluate the level of changes in the expression of mir-223, mir-92a and mir-222 during storage in platelets prepared by platele...

full text

Clinical Evaluation of Platelet Concentrates Either in Plasma or in Addi- tive Solution

Background and Objectives. Platelet concentrates (PC) obtained from Buffy-Coat (BC) may be diluted in a platelet additive solution (PAS). These PCs may reduce plasma-related adverse reactions. We have tried to assess the relationship between PAS PCs and adverse reactions. Materials and Methods. During 6 months, patients treated with intensive chemotherapy, participated in a prospective study an...

full text

Comparative Study of Four Platelet-Rich Plasma Methods for Preparing Platelet Concentrates

Background: Platelet preparations have been used for a wide variety of clinical applications such as hemorrhage, tissue engineering and cellular therapy. Platelet concentrates can be prepared by the apheresis method or from the whole blood using the Buffy-coat or Platelet-rich plasma methods. The purpose of this study was to compare four variations of platelet-rich plasma method based on double...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of pediatric hematology and oncology

جلد ۱، شماره ۳، صفحات ۸۳-۸۹

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023